Archives
-
Cell Counting Kit-8 (CCK-8) Plus Protocol Guide
2026-09-15
Cell Counting Kit-8 (CCK-8) Plus provides a rapid WST-8-based colorimetric readout for estimating viable-cell abundance in proliferation, cytotoxicity, and drug screening workflows. It should be used as a metabolic viability measurement within a validated linear range, not as a direct cell counter or a standalone proof of a specific cell-death mechanism.
-
Primary Antibody Dilution Buffer in CNS Lymphoma
2026-09-15
A translational perspective on how the Primary Antibody Dilution Buffer can support tissue-level validation of SLC2A5-mediated fructose metabolism in primary CNS lymphoma, while keeping assay performance, evidence boundaries, and workflow strategy in view.
-
Ionizing Radiation Rewires Neuronal Differentiation
2026-09-14
The reference study shows that ionizing radiation does more than reduce neural stem-cell viability: it drives an altered neuronal differentiation program in C17.2 cells through PI3K-linked STAT3–mGluR1 and p53 signaling. Its combination of morphological, molecular, pharmacological, and primary-cell evidence provides a useful framework for studying how radiotherapy may disrupt later neural function.
-
Ceruletide Workflows for Pancreatic Fibrosis Research
2026-09-14
Ceruletide, also known as Caerulein, provides a controllable CCK-receptor challenge for pancreatic injury, secretion, and gastrointestinal motility experiments. This guide connects practical reagent handling with fibrosis-focused readouts inspired by recent MFGE8–ANXA1–SMAD2/3 research.
-
Dual HER2–VEGFR2 Targeting in TNBC
2026-09-13
A 2026 study examined lapatinib and Telatinib (BAY 57-9352) in HER2-negative MDA-MB-231 triple-negative breast cancer cells. The combination reduced proliferation, invadopodia formation, and two-dimensional angiogenic tube formation, while also highlighting the mechanistic and translational limits of inferring HER2/VEGFR2 target engagement from phenotype alone.
-
Persistent rDNA Damage and PML-Nucleolar Compartments
2026-09-12
The reference study identifies persistent ribosomal DNA lesions, rather than generic genotoxicity alone, as a trigger for PML-nucleolar associations. By combining topological-stress treatments, targeted I-PpoI cleavage, repair-pathway perturbation, and imaging of DNA-repair markers, it provides a mechanistic framework linking rDNA damage, incomplete homologous recombination, nucleolar compartmentalization, and senescence.
-
DFO: Chemistry, Context, and Assay Design
2026-09-11
DFO (9H-1,8-Diazafluoren-9-one) is more than a fluorescent fingerprint reagent: its value depends on chemical identity, substrate context, and controlled handling. This guide connects latent print chemistry with a critical analysis of a biomaterials study that uses a different compound abbreviated DFO.
-
RIPA Lysis Buffer Strong: Practical Use Guide
2026-09-11
RIPA Lysis Buffer Strong provides detergent-based extraction for animal cells and tissues when efficient membrane disruption is needed for protein analysis. Because it contains no protease or phosphatase inhibitors, it should be supplemented immediately for sensitive targets and is less suitable for workflows involving delayed processing or native-complex preservation.
-
Prochlorperazine Workflows for Antiemetic and Cancer Researc
2026-09-10
Prochlorperazine combines dopamine D2 receptor antagonism with experimentally useful effects on melanoma phenotypes and viral entry pathways. This practical guide converts those properties into reproducible dosing, migration, cytotoxicity, and time-of-addition workflows while separating established evidence from hypothesis-generating applications.
-
Cholecystokinin octapeptide ammonium Assay Guide
2026-09-10
Build more reproducible CCK receptor experiments with a workflow that connects receptor activation to ROS, PGC-1α, PPAR signaling, ANP release, and behavioral or cellular endpoints. This guide emphasizes sulfation-aware controls, concentration selection, handling of an insoluble peptide, and troubleshooting across cardiac, neuronal, immune, and behavioral models.
-
Resazurin Cell Viability Assay Kit for Bone Research
2026-09-09
The Resazurin Cell Viability Assay Kit provides a sensitive, non-toxic way to quantify living cells by fluorescence or colorimetry, making it useful for dose-response studies and high-throughput screening. In skeletal disease research, it can complement pathway, differentiation, and imaging endpoints without replacing mechanistic validation.
-
Resazurin Cell Viability Assay in Sclerosteosis
2026-09-09
Learn how the Resazurin Cell Viability Assay Kit can separate cell-health effects from osteogenic efficacy in Wnt-driven sclerosteosis research. This article develops an assay strategy grounded in PORCN inhibition, metabolic readout limitations, and orthogonal bone endpoints.
-
Maridomycin Study: Leucomycin Activity and Resistance
2026-09-08
The reference study established a broad phenotypic profile for maridomycin by combining susceptibility testing, resistance selection, serum-binding analysis, bactericidal measurements, and mouse infection models. Its main practical contribution was to connect in vitro antibacterial behavior with therapeutic activity while showing both cross-resistance among macrolides and activity against selected resistant staphylococci.
-
Cholecystokinin Octapeptide Ammonium: Mechanism
2026-09-08
Cholecystokinin octapeptide ammonium, also called CCK-8 ammonium, is a sulfated brain–gut peptide reagent that engages CCK1R and CCK2R signaling. Evidence in morphine-withdrawal rats supports a CCK1R-dependent reduction of anxiety-like behavior, while product documentation describes broader concentration-dependent neuroendocrine, immune, apoptotic, and cardiovascular research uses.
-
Luminescent ATP Cell Viability Assay Kit I in Ferroptosis
2026-09-07
Learn how the Luminescent ATP Cell Viability Assay Kit I converts intracellular ATP into a rapid, sensitive viability readout for ferroptosis research. This guide focuses on interpreting ATP loss mechanistically, designing controls, and translating luciferase luminescence detection into reliable cytotoxicity data.